학술논문
Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1477092X